$85.56 +0.42 (%) Gilead Sciences Inc - NASDAQ

Feb. 8, 2016 | 03:55 PM

Partner Headlines

  1. How To Invest In An Aging World With The 'Live Long & Prosper' ETF

    Benzinga | Feb. 8, 2016 | 10:53AM EST
  2. Bill Gates, Apple Chair, Nike CEO Lead Week’s Insider Trades

    IBD | Feb. 5, 2016 | 13:45PM EST
  3. Strong Dollar Pounds S&P 500 Into Earnings Recession

    IBD | Feb. 5, 2016 | 08:02AM EST
  4. Gilead Sciences Rallies Off Q4 Report

    Benzinga | Feb. 3, 2016 | 15:10PM EST
  5. Zika-Related Social Media Chatter Is Picking Up

    Benzinga | Feb. 3, 2016 | 13:40PM EST
  6. Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits High

    IBD | Feb. 3, 2016 | 13:05PM EST
  7. Benzinga's Top Initiations

    Benzinga | Feb. 3, 2016 | 09:45AM EST
  8. Keep an Eye on These 10 Stocks for February 3, 2016

    Benzinga | Feb. 3, 2016 | 04:28AM EST
  9. Gilead Trounces Hep C Estimates; Harvoni International Footprint Nearly Equals U.S.

    Benzinga | Feb. 2, 2016 | 17:17PM EST
  10. Earnings Recap For February 2

    Benzinga | Feb. 2, 2016 | 16:45PM EST
  11. Plenty of Opportunity to Buy Individual Stocks: John Buckingham

    GuruFocus | Feb. 2, 2016 | 12:32PM EST
  12. Apple: Think Differently From the Analysts

    GuruFocus | Feb. 1, 2016 | 15:13PM EST
  13. Gilead Hits New 52-Week Low; Here Are Two Reasons Why

    Benzinga | Jan. 29, 2016 | 13:32PM EST
  14. Worst Performing Industries For January 29, 2016

    Benzinga | Jan. 29, 2016 | 12:08PM EST
  15. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  16. Gilead Sciences Now Holds 14.75% of Galapagos Shares

    Benzinga | Jan. 25, 2016 | 04:11AM EST
  17. Jim Cramer Dishes On Microsoft, Gilead, TG Therapeutics & NY Community Bancorp

    Benzinga | Jan. 24, 2016 | 19:56PM EST
  18. Gilead Sciences Tumbles; Unconfirmed Reports Of Drug Pricing Changes In Japan

    Benzinga | Jan. 20, 2016 | 12:07PM EST
  19. GILEAD SCIENCES

    IBD | Jan. 19, 2016 | 18:48PM EST
  20. The Best Reason to Love Gilead's Market Correction

    GuruFocus | Jan. 18, 2016 | 16:35PM EST
  21. Rethink U.S. Large-Cap Exposure With This ETF

    Benzinga | Jan. 15, 2016 | 13:25PM EST
  22. Amazon Gets New Call; Disney Downgraded Amid Netflix

    IBD | Jan. 15, 2016 | 09:12AM EST
  23. Gurus Are Buying These Stocks Trading Below Peter Lynch value

    GuruFocus | Jan. 14, 2016 | 17:27PM EST
  24. Galapagos, Gilead Cleared FTC to Close Global Partnership on Filgotinib

    Benzinga | Jan. 13, 2016 | 04:20AM EST
  25. Moving To Momentum With ETFs

    Benzinga | Jan. 12, 2016 | 07:28AM EST
  26. Apple Supplier Avago, Guns, Gilead Top Insider Trades

    IBD | Jan. 8, 2016 | 15:10PM EST
  27. Why Gilead Is 'The Apple Of Biotech'

    Benzinga | Jan. 7, 2016 | 16:36PM EST
  28. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  29. Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences

    Benzinga | Jan. 7, 2016 | 06:35AM EST
  30. A Calmer Year For Pharma?

    IBD | Jan. 6, 2016 | 18:47PM EST
  31. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  32. Gilead Sciences

    IBD | Jan. 5, 2016 | 18:56PM EST
  33. Stocks End Mixed; Apple Drops, Macom Hits Sell Signal

    IBD | Jan. 5, 2016 | 16:32PM EST
  34. GILEAD SCIENCES

    IBD | Jan. 4, 2016 | 18:42PM EST
  35. Gilead, Other Biotechs Selling Off On Market Weakness

    Benzinga | Jan. 4, 2016 | 14:22PM EST
  36. Berkshire Hathaway: Dividends Are Coming; Why Not In 2016?

    GuruFocus | Dec. 31, 2015 | 13:06PM EST
  37. Here are My Top Ten Stock Picks for 2016

    GuruFocus | Dec. 30, 2015 | 15:58PM EST
  38. An Award-Winning Debut For This Goldman ETF

    Benzinga | Dec. 23, 2015 | 09:54AM EST
  39. Tesla, First Solar, Gilead Lead Week's Insider Deals

    IBD | Dec. 21, 2015 | 17:50PM EST
  40. Ackman, Sequoia Stock Valeant Changes Course

    GuruFocus | Dec. 18, 2015 | 17:46PM EST
  41. Glaxo's ViiV Acquiring Bristol-Myers' HIV Candidates

    IBD | Dec. 18, 2015 | 14:05PM EST
  42. Tesla, First Solar, Gilead Lead Week's Insider Deals

    IBD | Dec. 18, 2015 | 13:11PM EST
  43. Jim Chanos - Likes Gilead, Still Short Valeant

    GuruFocus | Dec. 18, 2015 | 12:11PM EST
  44. Gilead in Galapagos drug deal

    IBD | Dec. 17, 2015 | 19:25PM EST
  45. Gilead Buys Into Galapagos Drug That AbbVie Ditched

    IBD | Dec. 17, 2015 | 14:01PM EST
  46. Benzinga's Volume Movers

    Benzinga | Dec. 17, 2015 | 10:24AM EST
  47. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 17, 2015 | 08:19AM EST
  48. Galapagos, Gilead Announce Global Partnership to Develop Filgotinib to Treat Rheumatoid Arthritis, Other Inflammatory Diseases

    Benzinga | Dec. 17, 2015 | 04:14AM EST
  49. Generating 15% Returns Using the Growth Rating System

    GuruFocus | Dec. 14, 2015 | 12:45PM EST
  50. Weekly CFO Sells Highlight: Tyson Foods, Alexion Pharmaceuticals, Gilead Sciences

    GuruFocus | Dec. 13, 2015 | 01:35AM EST
Trading Center